ID

36573

Descripción

Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01784757

Link

https://clinicaltrials.gov/show/NCT01784757

Palabras clave

Versiones (2)
  1. 17/1/19 17/1/19 -
  2. 22/5/19 22/5/19 -
Titular de derechos de autor

Orion Corporation, Orion Pharma

Subido en

22 de mayo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Bioavailability of ODM-201 in Prostate Cancer NCT01784757

Inglés

Eligibility Criteria

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent (ic) obtained.
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
histologically confirmed adenocarcinoma of prostate
Descripción

histologically confirmed adenocarcinoma of prostate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0679557
UMLS CUI [1,2]
C0007112
progressive metastatic disease
Descripción

progressive metastatic disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2939420
UMLS CUI [1,2]
C0205329
ongoing androgen deprivation therapy with a luteinising hormone-releasing hormone (LHRH) analogue or antagonist or bilateral orchiectomy
Descripción

ongoing androgen deprivation therapy with LHRH analogue or antagonist or bilateral orchiectomy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C0279492
UMLS CUI [1,3]
C1518041
UMLS CUI [2,1]
C0521116
UMLS CUI [2,2]
C0279492
UMLS CUI [2,3]
C1276926
UMLS CUI [3]
C0194875
adequate bone marrow, hepatic and renal function
Descripción

adequate bone marrow, hepatic and renal function

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
able to swallow the ODM-201 whole as a capsule or tablet
Descripción

able to swallow study treatment as capsule or tablet

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0006935
UMLS CUI [2,1]
C2712086
UMLS CUI [2,2]
C0039225
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous chemotherapy for prostate cancer
Descripción

previous chemotherapy for prostate cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0600139
known metastases in the brain
Descripción

known metastases in the brain

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0220650
history of other malignancy within the previous 5 years, except a basal cell carcinoma of skin
Descripción

history of other malignancy, except a basal cell carcinoma of skin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0006826
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C0007117
UMLS CUI [2,3]
C1123023
known gastrointestinal condition that can significantly affect the absorption of the study treatment
Descripción

known gastrointestinal condition that can significantly affect the absorption of the study treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0017178
UMLS CUI [1,2]
C0750502
UMLS CUI [1,3]
C0392760
UMLS CUI [1,4]
C0237442
UMLS CUI [1,5]
C0013230
Volver a la parte superior de la página

Similar models

Eligibility Criteria

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed consent
Item
written informed consent (ic) obtained.
boolean
C0021430 (UMLS CUI [1])
histologically confirmed adenocarcinoma of prostate
Item
histologically confirmed adenocarcinoma of prostate
boolean
C0679557 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
progressive metastatic disease
Item
progressive metastatic disease
boolean
C2939420 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
ongoing androgen deprivation therapy with LHRH analogue or antagonist or bilateral orchiectomy
Item
ongoing androgen deprivation therapy with a luteinising hormone-releasing hormone (LHRH) analogue or antagonist or bilateral orchiectomy
boolean
C0521116 (UMLS CUI [1,1])
C0279492 (UMLS CUI [1,2])
C1518041 (UMLS CUI [1,3])
C0521116 (UMLS CUI [2,1])
C0279492 (UMLS CUI [2,2])
C1276926 (UMLS CUI [2,3])
C0194875 (UMLS CUI [3])
adequate bone marrow, hepatic and renal function
Item
adequate bone marrow, hepatic and renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
able to swallow study treatment as capsule or tablet
Item
able to swallow the ODM-201 whole as a capsule or tablet
boolean
C2712086 (UMLS CUI [1,1])
C0006935 (UMLS CUI [1,2])
C2712086 (UMLS CUI [2,1])
C0039225 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
previous chemotherapy for prostate cancer
Item
previous chemotherapy for prostate cancer
boolean
C1514457 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
known metastases in the brain
Item
known metastases in the brain
boolean
C0220650 (UMLS CUI [1])
history of other malignancy, except a basal cell carcinoma of skin
Item
history of other malignancy within the previous 5 years, except a basal cell carcinoma of skin
boolean
C0262926 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C2828389 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1123023 (UMLS CUI [2,3])
known gastrointestinal condition that can significantly affect the absorption of the study treatment
Item
known gastrointestinal condition that can significantly affect the absorption of the study treatment
boolean
C0017178 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0237442 (UMLS CUI [1,4])
C0013230 (UMLS CUI [1,5])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial